These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 33269387)
1. Raloxifene is a Female-specific Proteostasis Therapeutic in the Spinal Cord. Jenkins EC; Casalena G; Gomez M; Zhao D; Kenny TC; Shah N; Manfredi G; Germain D Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33269387 [TBL] [Abstract][Full Text] [Related]
2. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects. Muchmore DB Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275 [TBL] [Abstract][Full Text] [Related]
3. Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start. Veenman L Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066585 [TBL] [Abstract][Full Text] [Related]
4. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements. Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307 [TBL] [Abstract][Full Text] [Related]
5. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene. Thiebaud D; Secrest RJ Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172 [TBL] [Abstract][Full Text] [Related]
6. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Peng J; Sengupta S; Jordan VC Anticancer Agents Med Chem; 2009 Jun; 9(5):481-99. PubMed ID: 19519291 [TBL] [Abstract][Full Text] [Related]
7. The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation. Sfogliarini C; Pepe G; Cesta CM; Allegretti M; Locati M; Vegeto E Biomed Pharmacother; 2023 Sep; 165():115008. PubMed ID: 37442065 [TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Park WC; Jordan VC Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274 [TBL] [Abstract][Full Text] [Related]
9. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Treatment of Tamoxifen and Raloxifene Alleviates Dystrophic Phenotype and Enhances Muscle Functions of FKRP Dystroglycanopathy. Wu B; Shah SN; Lu P; Bollinger LE; Blaeser A; Sparks S; Harper AD; Lu QL Am J Pathol; 2018 Apr; 188(4):1069-1080. PubMed ID: 29571322 [TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins. Lonard DM; Tsai SY; O'Malley BW Mol Cell Biol; 2004 Jan; 24(1):14-24. PubMed ID: 14673139 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling. Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829 [TBL] [Abstract][Full Text] [Related]
13. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells. Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881 [TBL] [Abstract][Full Text] [Related]
14. Searching for an ideal SERM: Mining tamoxifen structure-activity relationships. Price S; Bender SG; Yahn R; Till NA; Varady S; LaLonde RL Bioorg Med Chem Lett; 2021 Nov; 52():128383. PubMed ID: 34592434 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease. Poirier AA; Côté M; Bourque M; Morissette M; Di Paolo T; Soulet D Neurobiol Aging; 2016 Dec; 48():61-71. PubMed ID: 27644075 [TBL] [Abstract][Full Text] [Related]
16. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. Nalbandian G; Paharkova-Vatchkova V; Mao A; Nale S; Kovats S J Immunol; 2005 Aug; 175(4):2666-75. PubMed ID: 16081843 [TBL] [Abstract][Full Text] [Related]
17. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072 [TBL] [Abstract][Full Text] [Related]
18. Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation. Sudhakar R; Adhikari N; Pamnani S; Panda A; Bhattacharjee M; Rizvi Z; Shehzad S; Gupta D; Sijwali PS Microbiol Spectr; 2022 Jun; 10(3):e0278121. PubMed ID: 35616371 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen to raloxifene and beyond. O'Regan RM; Jordan VC Semin Oncol; 2001 Jun; 28(3):260-73. PubMed ID: 11402436 [TBL] [Abstract][Full Text] [Related]
20. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials. Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]